Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs DR. REDDYS LAB - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES DR. REDDYS LAB ZYDUS LIFESCIENCES/
DR. REDDYS LAB
 
P/E (TTM) x 22.7 20.7 109.4% View Chart
P/BV x 2.8 3.9 72.1% View Chart
Dividend Yield % 0.5 0.7 78.8%  

Financials

 ZYDUS LIFESCIENCES   DR. REDDYS LAB
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
DR. REDDYS LAB
Mar-22
ZYDUS LIFESCIENCES/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs6745,614 12.0%   
Low Rs3313,655 9.1%   
Sales per share (Unadj.) Rs149.11,294.6 11.5%  
Earnings per share (Unadj.) Rs22.7126.9 17.9%  
Cash flow per share (Unadj.) Rs29.7196.9 15.1%  
Dividends per share (Unadj.) Rs2.5030.00 8.3%  
Avg Dividend yield %0.50.6 76.9%  
Book value per share (Unadj.) Rs166.11,145.8 14.5%  
Shares outstanding (eoy) m1,023.74166.43 615.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.43.6 94.1%   
Avg P/E ratio x22.136.5 60.5%  
P/CF ratio (eoy) x16.923.5 71.9%  
Price / Book Value ratio x3.04.0 74.8%  
Dividend payout %11.023.6 46.5%   
Avg Mkt Cap Rs m514,277771,272 66.7%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77738,858 56.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652215,452 70.9%  
Other income Rs m2,3544,847 48.6%   
Total revenues Rs m155,006220,299 70.4%   
Gross profit Rs m34,42737,674 91.4%  
Depreciation Rs m7,13011,652 61.2%   
Interest Rs m1,270958 132.6%   
Profit before tax Rs m28,38129,911 94.9%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1178,789 58.2%   
Profit after tax Rs m23,26421,122 110.1%  
Gross profit margin %22.617.5 129.0%  
Effective tax rate %18.029.4 61.4%   
Net profit margin %15.29.8 155.5%  
BALANCE SHEET DATA
Current assets Rs m122,614177,880 68.9%   
Current liabilities Rs m78,39497,658 80.3%   
Net working cap to sales %29.037.2 77.8%  
Current ratio x1.61.8 85.9%  
Inventory Days Days9356 166.3%  
Debtors Days Days80113 70.6%  
Net fixed assets Rs m144,382106,819 135.2%   
Share capital Rs m1,024832 123.1%   
"Free" reserves Rs m168,972189,859 89.0%   
Net worth Rs m169,996190,691 89.1%   
Long term debt Rs m3,6215,746 63.0%   
Total assets Rs m266,996284,699 93.8%  
Interest coverage x23.332.2 72.5%   
Debt to equity ratio x00 70.7%  
Sales to assets ratio x0.60.8 75.5%   
Return on assets %9.27.8 118.5%  
Return on equity %13.711.1 123.5%  
Return on capital %17.115.7 108.7%  
Exports to sales %047.1 0.0%   
Imports to sales %14.318.8 76.4%   
Exports (fob) Rs mNA101,544 0.0%   
Imports (cif) Rs m21,86940,401 54.1%   
Fx inflow Rs m63,065101,544 62.1%   
Fx outflow Rs m21,86940,401 54.1%   
Net fx Rs m41,19661,143 67.4%   
CASH FLOW
From Operations Rs m21,04128,108 74.9%  
From Investments Rs m11,544-26,387 -43.7%  
From Financial Activity Rs m-8,683-2,422 358.5%  
Net Cashflow Rs m23,72932 74,153.1%  

Share Holding

Indian Promoters % 75.0 26.7 280.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 16.2 50.7 32.0%  
FIIs % 2.5 27.3 9.2%  
ADR/GDR % 0.0 10.5 -  
Free float % 25.0 62.8 39.9%  
Shareholders   370,396 246,788 150.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   SUN PHARMA    CIPLA    LUPIN    AUROBINDO PHARMA    LAURUS LABS     


More on Cadila Healthcare vs Dr. Reddys

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Cadila Healthcare vs Dr. Reddys Share Price Performance

Period Cadila Healthcare Dr. Reddys S&P BSE HEALTHCARE
1-Day -1.10% 1.00% 1.20%
1-Month 6.98% 3.54% -3.18%
1-Year 18.32% 3.84% -7.59%
3-Year CAGR 19.36% 12.50% 16.43%
5-Year CAGR 3.22% 15.54% 9.40%

* Compound Annual Growth Rate

Here are more details on the Cadila Healthcare share price and the Dr. Reddys share price.

Moving on to shareholding structures...

The promoters of Cadila Healthcare hold a 75.0% stake in the company. In case of Dr. Reddys the stake stands at 26.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Cadila Healthcare and the shareholding pattern of Dr. Reddys.

Finally, a word on dividends...

In the most recent financial year, Cadila Healthcare paid a dividend of Rs 2.5 per share. This amounted to a Dividend Payout ratio of 11.0%.

Dr. Reddys paid Rs 30.0, and its dividend payout ratio stood at 23.6%.

You may visit here to review the dividend history of Cadila Healthcare, and the dividend history of Dr. Reddys.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15% Sensex Today Ends 378 Points Higher | Nifty Ends Above 17,850 | Paytm & Adani Enterprises Rally 15%(Closing)

After opening the day on a positive note, Indian share markets continued their momentum as the session progressed and ended higher.